Live Quote · NASDAQSNTIHealthcare· Biotechnology

Senti Biosciences, Inc.

$1.07 0.94%(+$0.01)
TickerSpark Score
43/100
Weak
27
Valuation
20
Profitability
60
Growth
56
Health
50
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SNTI research report →

52-Week Range14% of range
Low
$0.77
Current
$1.07
High
$2.88
Company Overviewwww.sentibio.com

About the company

Senti Biosciences, Inc. is a pioneering company specializing in gene circuit technology. They focus on creating advanced cell and gene therapies that incorporate sophisticated gene circuits, essentially biological computers, to genetically reprogram cells.

CEO
Timothy K. Lu
IPO
2021
Employees
34
HQ
South San Francisco, CA, US

Price Chart

-51.58% · this period
$2.39$1.58$0.77Jul 02Dec 31Jul 02
Valuation
Market Cap
$28.13M
P/E
-0.56
P/S
740.29
P/B
12.92
EV/EBITDA
-0.80
Div Yield
0.00%
Profitability
Gross Margin
-8513.16%
Op Margin
-154810.53%
Net Margin
-135650.00%
ROE
-503.79%
ROIC
-196.99%
Growth & Income
Revenue
$22.00K · 0.00%
Net Income
$-61,438,000 · -16.38%
EPS
$-2.73 · 76.24%
Op Income
$-63,727,000
FCF YoY
-5.35%
Performance & Tape
52W High
$2.88
52W Low
$0.77
50D MA
$0.99
200D MA
$1.25
Beta
2.05
Avg Volume
198.36K

Get TickerSpark's AI analysis on SNTI

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Mar 9, 26Rajangam Kanyaother10,757
Mar 9, 26Lu Timothy Kother80,666
Feb 2, 26Rajangam Kanyaother1,384
Feb 2, 26Lu Timothy Kother4,191
Jul 18, 25Baum Bryan Danielother43,900
Jul 18, 25Baum Bryan Danielother0
Jun 25, 25Collins James J.other21,950
Jun 25, 25Hsiung Fengother21,950
Jun 25, 25Schulz Franother21,950
Jun 25, 25COOPERSTONE BRENDAother21,950
Coverage · SNTI

Our SNTI coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on SNTI yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate SNTI report →
Internal Compare

Similar companies

Peers in the same neighborhood.